Supplementary Figure S1 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407860

2023-01-01

Abstract:Myeloid cells, CCL9 and its effect on tumor phenotype.

What problem does this paper attempt to address?

Supplementary Figure S4 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407851

2023-01-01

Abstract:CCL9 promotes tumor cell survival and colonization.
Supplementary Figure S6 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407845

2023-01-01

Abstract:Fold increase in myeloid cell subsets in the lungs.
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.
CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.

Hangyi H. Yan,Jian Jiang,Yanli Pang,B. R. Achyut,Michael Lizardo,Xinhua Liang,Kent Hunter,Chand Khanna,Christine Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.can-15-2282-t

IF: 11.2

2015-01-01

Cancer Research

Abstract:AbstractTumor cell survival in the hostile distant organ is a rate-limiting step in cancer metastasis. Bone marrow–derived myeloid cells can form a premetastatic niche and provide a tumor-promoting microenvironment. However, it is unclear whether these myeloid cells in the premetastatic site have any direct effect on tumor cell survival. Here, we report that chemokine CCL9 was highly induced in Gr-1+CD11b+ immature myeloid cells and in premetastatic lung in tumor-bearing mice. Knockdown of CCL9 in myeloid cells decreased tumor cell survival and metastasis. Importantly, CCL9 overexpression in myeloid cells lacking TGFβ signaling rescued the tumor metastasis defect observed in mice with myeloid-specific Tgfbr2 deletion. The expression level of CCL23, the human orthologue for CCL9, in peripheral blood mononuclear cells correlated with progression and survival of cancer patients. Our study demonstrates that CCL9 could serve as a good candidate for anti-metastasis treatment by targeting the rate-limiting step of cancer cell survival. In addition, targeting CCL9 may avoid the adverse effects of TGFβ-targeted therapy. Cancer Res; 75(24); 5283–98. ©2015 AACR.
Supplementary Figure 9 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530042.v1

2023-01-01

Abstract:Supplementary Figure 9 - PDF file 150K, Gating strategy, sorting efficiency, and TbetaRII expression in myeloid cell subsets
Abstract 3172: CCL9 Induction in Myeloid Cells of the Premetastatic Niche Enhances Tumor Cell Survival and Metastatic Colonization

Hannah H. Y. Yan,Yanli Pang,Kent Hunter,Chand Khanna,Li Yang

DOI: https://doi.org/10.1158/1538-7445.am2015-3172

IF: 11.2

2015-01-01

Cancer Research

Abstract:Abstract Tumor cell survival in the hostile distant organ is a rate-limiting step in cancer metastasis. Bone marrow-derived myeloid cells can form a premetastatic niche and provide a tumor-promoting microenvironment. However, it is unclear whether these myeloid cells in the premetastatic site have any direct effect on tumor cell survival. Here we report that chemokine CCL9 was highly induced in Gr-1+CD11b+ immature myeloid cells and in premetastatic lung of mice bearing 4T1 mammary tumor and B16 melanoma. Knockdown of CCL9 in myeloid cells decreased tumor cell survival and metastasis. The expression level of CCL23, the human orthologue for CCL9, in peripheral blood mononuclear cells correlated with progression and survival of cancer patients. Our studies identify CCL9 as a key pro-survival factor for cancer cells in the premetastatic organ. Interestingly, the expression of CCL9 in myeloid cells is regulated by TGF-β signaling as overexpression of CCL9 in myeloid cells lacking TGF-β signaling rescued the tumor metastasis defect observed in mice with myeloid-specific deletion of TGF-β signaling. These data together with our previous report of a fundamental role of myeloid TGF-β signaling in host compromised immune surveillance (Cancer Discovery 2013); demonstrate that myeloid-specific TGF-β signaling constitutes an essential component of the metastasis-promoting puzzle of TGF-β. This finding is different from TGF-β signaling in fibroblasts and a variety of epithelial cells, as well as T cells in which the TGF-β signaling functions as a tumor suppressor. This new understanding of TGF-β at the interface of tumor and host may provide insight into how TGF-β switches from a tumor suppressor to a tumor promoter, a long-standing challenge in cancer biology field. Our study demonstrates that CCL9 could serve as a good candidate for anti-metastasis treatment by targeting the rate-limiting step of cancer cell survival. Additionally, targeting CCL9 may avoid the adverse effects of TGF-β-targeted therapy. Citation Format: Hannah HY Yan, Yanli Pang, Kent Hunter, Chand Khanna, Li Yang. CCL9 induction in myeloid cells of the premetastatic niche enhances tumor cell survival and metastatic colonization. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3172. doi:10.1158/1538-7445.AM2015-3172
Supplementary Figure 7 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530048.v1

2023-01-01

Abstract:Supplementary Figure 7 - PDF file 111K, Characterization of myeloid cells in lung, tumor, spleen, and lymph nodes
Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Sonia Patel,Monique B. Nilsson,Yan Yang,Xiuning Le,Hai T. Tran,Yasir Y. Elamin,Xiaoxing Yu,Fahao Zhang,Alissa Poteete,Xiaoyang Ren,Ли Шен,Jing Wang,Seyed Javad Moghaddam,Tina Cascone,Michael A. Curran,Don L. Gibbons,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22490453.v1

2023-01-01

Abstract:EGFR-mutant NSCLC tumor cells with acquired resistance to an EGFR-TKI display augmented IL-6 gene expression.
Supplementary Figure 8 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530045.v1

2023-01-01

Abstract:Supplementary Figure 8 - PDF file 84K, Immune cell profiling and IFN-gamma production in CD8 T cells in tumor tissues between Tgfbr2flox/flox and Tgfbr2MyeKO mice bearing 4T1 tumors
Supplementary Figure 6 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530051.v1

2023-01-01

Abstract:Supplementary Figure 6 - PDF file 115K, IFN-gamma production in different myeloid cell subsets, and factors that mediate IFN-gamma production
Supplementary Figure 3 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530060.v1

2023-01-01

Abstract:Supplementary Figure 3 - PDF file 76K, IFN-gamma production by T cells and its effect on tumor growth in Tgfbr2MyeKOand Tgfbr2flox/flox control mice
Supplementary Figure S3 from TNFRSF19 Inhibits TGFβ Signaling Through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis

Chengcheng Deng,Yuxin Lin,Xue-Kang Qi,Guangcun He,Yuchen Zhang,Hao-Jiong Zhang,Mingwei Xu,Feng Qian,Jin‐Xin Bei,Yi‐Xin Zeng,Feng Li

DOI: https://doi.org/10.1158/0008-5472.22419515.v1

2023-01-01

Abstract:Supplementary Figure S3 from TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis
Figure S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Xue Meng,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Li,Xiu‐Ping Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419846.v1

2023-01-01

Abstract:Supplementary figure S2. Gating strategies for flow cytometry analyses.
Supplementary Figures 1-7 from Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung

Hannah H. Yan,Michael Pickup,Yanli Pang,Agnieszka E. Gorska,Zhaoyang Li,Anna Chytil,Yipeng Geng,Jerome W. Gray,Harold L. Moses,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22382760.v1

2023-01-01

Abstract:Supplementary Figures 1-7 from Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung
Supplementary Figure S1 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142144

2024-01-01

Abstract:Supplementary Figure S1. CCL22-expressing cDC are associated with worse survival in cancer patients
Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Feng Xu,Jing Liu,Di Liu,Biao Liu,Min Wang,Zhiyuan Hu,Xuemei Du,Li Tang,Fuchu He

DOI: https://doi.org/10.1158/0008-5472.22399947.v1

2023-01-01

Abstract:PDF file - 31KB, Supplementary Figure 2 Determination of concentration of IL-6 and IL-10 within tumor.
Supplemental Figure S2 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Jing Huang,Lin Xiao,Xiaoting Gong,Wenwei Shao,Yanhui Yin,Qinyuan Liao,Yang Meng,Yingmei Zhang,Dalong Ma,Xiaoyan Qiu

DOI: https://doi.org/10.1158/0008-5472.22402082

2023-01-01

Abstract:CCDC134 has no apparent effect on activation, effector function and proliferation of mouse CD4+ T cells.
Spleen-Derived CCL9 Recruits MDSC to Facilitate Tumor Growth in Orthotopic Hepatoma Mice

Baohua Li,Wenjuan Li,Yingxue Liang,Chen Zhang,Guangyao Kong,Zongfang Li

DOI: https://doi.org/10.1055/s-0043-1777327

2023-01-01

Global Medical Genetics

Abstract:Objectives Spleen is involved in multiple diseases, the role of the spleen and spleen-derived factors in hepatocellular carcinoma (HCC) is still not clarified.Methods In the current study, a murine H22 orthotopic hepatoma model was established. Three groups were divided: normal mice, tumor-bearing mice with spleen-preserving, and tumor-bearing mice with splenectomy. Spleen and tumor weights were recorded by weeks 1 and 2. The proportion of myeloid-derived suppressor cell (MDSC) in peripheral blood and tumor tissue was detected using flow cytometry. Protein chip assay was used to compare the differential cytokines between normal liver supernatant and tumor supernatant. The common upregulated cytokines both in spleen and tumor were focused and analyzed using gene expression profiling interactive analysis (GEPIA) database. Enzyme-linked immunosorbent assay was performed to verify the chip result, and to examine CCL9 expression before and after splenectomy. Spleen MDSC was sorted using flow cytometry, and chemotaxis assay was performed to demonstrate whether CCL9 attracted spleen MDSC.Results The spleen enlarged during tumor progression, and compared with splenectomy group, there were faster tumor growth, shorter survival time, and higher proportions of MDSC in spleen-preserving group. Protein chip assay and GEPIA database revealed CCL9 was the most promising chemokine involved in HCC upregulated both in spleen and tumor tissue. CCL9 attracted MDSC in vitro, the level of CCL9 in tumor tissue was downregulated, and the percentage of MDSC was decreased after splenectomy.Conclusion The results demonstrate that CCL9 may be derived from spleen; it facilitated HCC growth via the chemotaxis of MDSC, targeting CCL9 may be a promising strategy in HCC treatment.
TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis.

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi-Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.cd-12-0527

IF: 28.2

2013-01-01

Cancer Discovery

Abstract:Abstract TGF-β is overexpressed in advanced human cancers. It correlates with metastasis and poor prognosis. However, TGF-β functions as both a tumor suppressor and a tumor promoter. Here, we report for the first time that genetic deletion of Tgfbr2 specifically in myeloid cells (Tgfbr2MyeKO) significantly inhibited tumor metastasis. Reconstitution of tumor-bearing mice with Tgfbr2MyeKO bone marrow recapitulated the inhibited metastasis phenotype. This effect is mediated through decreased production of type II cytokines, TGF-β1, arginase 1, and inducible nitric oxide synthase, which promoted IFN-γ production and improved systemic immunity. Depletion of CD8 T cells diminished the metastasis defect in the Tgfbr2MyeKO mice. Consistent with animal studies, myeloid cells from patients with advanced-stage cancer showed increased TGF-β receptor II expression. Our studies show that myeloid-specific TGF-β signaling is an essential component of the metastasis-promoting puzzle of TGF-β. This is in contrast to the previously reported tumor-suppressing phenotypes in fibroblasts, epithelial cells, and T cells. Significance: Our study identifies myeloid-specific TGF-β signaling as a critical mediator in tumor metastasis, distinct from the tumor-suppressive effect of TGF-β signaling in epithelial cells, fibroblasts, and T cells. We further provide mechanistic insight into host antitumor immunity and suggest a cell type–specific cancer-targeting strategy. Cancer Discov; 3(8); 936–51. ©2013 AACR. See related commentary by Souza-Fonseca-Guimaraes and Smyth, p. 846 This article is highlighted in the In This Issue feature, p. 826
Supplementary Figure Legends 1-3, Table 1 from the Effect of CXCL12 Processing on CD34+ Cell Migration in Myeloproliferative Neoplasms

Sool Yeon Cho,Mingjiang Xu,John Roboz,Min Lu,John Mascarenhas,Ronald Hoffman

DOI: https://doi.org/10.1158/0008-5472.22386186.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-3, Table 1 from The Effect of CXCL12 Processing on CD34+ Cell Migration in Myeloproliferative Neoplasms

Supplementary Figure S1 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure S4 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure S6 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.

Supplementary Figure 9 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Abstract 3172: CCL9 Induction in Myeloid Cells of the Premetastatic Niche Enhances Tumor Cell Survival and Metastatic Colonization

Supplementary Figure 7 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Supplementary Figure 8 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure 6 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure 3 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure S3 from TNFRSF19 Inhibits TGFβ Signaling Through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis

Figure S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Figures 1-7 from Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung

Supplementary Figure S1 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplemental Figure S2 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Spleen-Derived CCL9 Recruits MDSC to Facilitate Tumor Growth in Orthotopic Hepatoma Mice

TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis.

Supplementary Figure Legends 1-3, Table 1 from the Effect of CXCL12 Processing on CD34+ Cell Migration in Myeloproliferative Neoplasms